Literature DB >> 7708664

Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

T C Nichols1, C M Samama, D A Bellinger, J Roussi, R L Reddick, M Bonneau, M S Read, O Bailliart, G G Koch, M Vaiman.   

Abstract

von Willebrand factor (vWF) is essential for the induction of occlusive thrombosis in stenosed and injured pig arteries and for normal hemostasis. To separate the relative contribution of plasma and platelet vWF to arterial thrombosis, we produced chimeric normal and von Willebrand disease pigs by crossed bone marrow transplantation; von Willebrand disease (vWD) pigs were engrafted with normal pig bone marrow and normal pigs were engrafted with vWD bone marrow. Thrombosis developed in the chimeric normal pigs that showed normal levels of plasma vWF and an absence of platelet vWF; but no thrombosis occurred in the chimeric vWD pigs that demonstrated normal platelet vWF and an absence of plasma vWF. The ear bleeding times of the chimeric pigs were partially corrected by endogenous plasma vWF but not by platelet vWF. Our animal model demonstrated that vWF in the plasma compartment is essential for the development of arterial thrombosis and that it also contributes to the maintenance of bleeding time and hemostasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7708664      PMCID: PMC42236          DOI: 10.1073/pnas.92.7.2455

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.

Authors:  E J Bowie; L A Solberg; D N Fass; C M Johnson; G J Knutson; M L Stewart; L J Zoecklein
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

2.  Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease.

Authors:  H R Gralnick; M E Rick; L P McKeown; S B Williams; R I Parker; P Maisonneuve; C Jenneau; Y Sultan
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

3.  Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

Authors:  V T Turitto; H J Weiss; T S Zimmerman; I I Sussman
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

4.  The possibility of detecting fetal lymphocytes in the maternal blood of the domestic pig, Sus scrofa.

Authors:  Z Rudek; L Kwiatkowska
Journal:  Cytogenet Cell Genet       Date:  1983

5.  Absence of tubular structures and immunolabeling for von Willebrand factor in the platelet alpha-granules from porcine von Willebrand disease.

Authors:  E M Cramer; J P Caen; L Drouet; J Breton-Gorius
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

6.  Platelet adhesion to damaged coronary arteries: Comparison in normal and von Willebrand disease swine.

Authors:  R L Reddick; T R Griggs; M A Lamb; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.

Authors:  E G Tuddenham; R S Lane; F Rotblat; A J Johnson; T J Snape; S Middleton; P B Kernoff
Journal:  Br J Haematol       Date:  1982-10       Impact factor: 6.998

8.  von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries.

Authors:  T C Nichols; D A Bellinger; T A Johnson; M A Lamb; T R Griggs
Journal:  Circ Res       Date:  1986-07       Impact factor: 17.367

9.  Biosynthesis of von Willebrand protein by human megakaryocytes.

Authors:  L A Sporn; S I Chavin; V J Marder; D D Wagner
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

10.  Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.

Authors:  K M Brinkhous; H Sandberg; J B Garris; C Mattsson; M Palm; T Griggs; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more
  17 in total

1.  Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis.

Authors:  S Kanaji; S A Fahs; Q Shi; S L Haberichter; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

Review 2.  von Willebrand factor.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease.

Authors:  Justin J Kang; Nayiri M Kaissarian; Karl C Desch; Robert J Kelly; Liming Shu; Peter F Bodary; James A Shayman
Journal:  Kidney Int       Date:  2018-11-22       Impact factor: 10.612

Review 4.  Platelet von Willebrand factor in inherited and acquired bleeding disorders.

Authors:  P M Mannucci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.

Authors:  J E Kaufmann; A Oksche; C B Wollheim; G Günther; W Rosenthal; U M Vischer
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

6.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

Review 7.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

8.  Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.

Authors:  Nirav Dhanesha; Prem Prakash; Prakash Doddapattar; Ira Khanna; Molly J Pollpeter; Manasa K Nayak; Janice M Staber; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-21       Impact factor: 8.311

9.  Platelet α-granules are required for occlusive high-shear-rate thrombosis.

Authors:  Dongjune A Kim; Katrina J Ashworth; Jorge Di Paola; David N Ku
Journal:  Blood Adv       Date:  2020-07-28

10.  Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.

Authors:  David A Brott; Anne Katein; Heath Thomas; Michael Lawton; Robert R Montgomery; Rudy J Richardson; Calvert S Louden
Journal:  Toxicol Pathol       Date:  2014-02-04       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.